Physician profile
Scott B Stevens
NPI 1740218635
$683.71
in general payments reported to CMS, 2019-2025
11 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $96.61 · 2023: $224 · 2024: $77.15 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $277.02 | 2021-2023 | Da Vinci Surgical System |
| Inari Medical, INC. | $105.13 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $49.05 | 2021 | |
| Smith+Nephew, INC. | $43.45 | 2025 | Collagenase Santyl, Renasys Touch, Pico |
| Mimedx Group, INC. | $39.25 | 2024 | |
| Baxter Healthcare | $34.02 | 2025 | Floseal |
| Boston Scientific Corporation | $33.80 | 2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Ethicon US, LLC | $31.82 | 2023 | Echelon; Endopath, Vistaseal, Enseal |
| Davol INC. | $25.92 | 2023 | Phasix Mesh |
| Tactile Systems Technology INC | $25.90 | 2025 | Flexitouch Plus, Nimbl |
| Lemaitre Vascular, INC. | $18.35 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.